NCT01827462 Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017) Status COMPLETED Phase PHASE4
NCT01825200 Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age Status COMPLETED Phase PHASE3
NCT01819155 Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa Status COMPLETED Phase PHASE2
NCT01816464 Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women Status COMPLETED Phase PHASE4
NCT01812980 Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women Status COMPLETED Phase PHASE4
NCT01811823 Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults Status COMPLETED Phase PHASE4
NCT01804946 Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza Status COMPLETED Phase PHASE4
NCT01797029 A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh Status COMPLETED Phase PHASE3
NCT01793883 Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza Status COMPLETED Phase PHASE2
NCT01788514 Combining Entertainment & Influenza Education for Pediatric Patients Status COMPLETED Phase NA
NCT01788228 Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure Status COMPLETED Phase PHASE3
NCT01779570 Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections Status COMPLETED Phase PHASE4
NCT01774032 H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older Status COMPLETED Phase PHASE3
NCT01773928 Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) Status COMPLETED Phase PHASE3
NCT01767896 Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine Status COMPLETED Phase PHASE3